INTEGRATED BIOPHARMA INC - 10-Q Filing
Integrated Biopharma reports 31.06 million shares outstanding for Q3 2026 period ending September 30.
Tickers: $INBP
More Regulatory news
- Rare Earths Americas, Inc. - 8-K Filing
- AVAI BIO, INC. - 10-Q Filing
- DYADIC INTERNATIONAL INC - 8-K Filing
- PCS Edventures!, Inc. - 10-Q Filing
- Royale Energy, Inc. - 10-Q Filing
- Blue Chip Capital Group Inc. - 8-K Filing
- MOVING iMAGE TECHNOLOGIES INC. - 10-Q Filing
- Harvard Apparatus Regenerative Technology, Inc. - 10-Q Filing
- Blue Acquisition Corp/Cayman - 8-K Filing
- Skyline Bankshares, Inc. - 10-Q Filing